PRLD
Prelude Therapeutics Inc
Price:  
4.38 
USD
Volume:  
3,693,041.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRLD Stock Forecast & Price Target

PRLD Stock Price Forecast

The average stock forecast for Prelude Therapeutics Inc (PRLD) in the next 12 months is 8.16 USD. This price target corresponds to an upside of 86.30%. The range of stock forecasts for PRLD is 6.06 - 10.50 USD. Based on the ratings of 9 analysts, the consensus recommendation for PRLD is BUY.
Target Low Average Median High
Price (USD) 6.06 8.16 8.16 10.50
Upside 38.36% 86.30% 86.30% 139.73%

Recommendation Trends

The latest consensus rating for PRLD is "BUY". This is the average recommendation of 9 analysts: 0 strong sell, 0 sell, 1 hold, 5 buy, 3 strong buy. In the previous period, 9 analysts also majorly recommmended "BUY" for PRLD.

PRLD Financial Stock Forecast

Revenue This Year
38.69M
218.66%
from 12.14M
Revenue Next Year
54.40M
40.62%
from 38.69M
EPS This Year
-0.56
-56.50%
from -1.29
EPS Next Year
-0.62
11.00%
from -0.56